View Author
expression receptor cancer tibolone phosphorylation endometrial effect study mutation progesterone patient isoform protein vector presence fraction invasion activity hcv replication replication peptide figure result androgen antibody level tumor growth absence lysate shrna sub-cell ishikawa -36 netherland inhibition e-cadherin endometrial cancer cells oh-tibolone hepatitis ifn-a control fibronectin prab -36 cells endometrial cancer analysis deficiency sub-cell lines integrin virus endocrinol hormone progesterone receptors androgen receptor 4- tibolone liver erasmu treatment culture ser -650 experiment subcell function library reticulocyte binding domain phosphorylated lentiviral table regulation identi luciferase activity r 1881 assay 110 kda isoform tenascin-c residue pattern interaction
8 Most Recent Publications
|
Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection
(Article)
Pan, Q. Ruiter, P.E. de Von Eije, K.J. Smits, R. Kwekkeboom, J. Tilanus, H.W. Berkhout, B. Janssen, H.L.A. Laan, L.J.W. van der |
2011-04-06
|
|
Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-α
(Article)
Pan, Q. Metselaar, H.J. Ruiter, P.E. de Kwekkeboom, J. Tilanus, H.W. Janssen, H.L.A. Laan, L.J.W. van der |
2010-04-01
|
|
Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins
(Article)
Hanekamp, E.E. Gielen, S.C.J.P. Ruiter, P.E. de Chadha-Ajwani, S. Huikeshoven, F.J. Burger, C.W. Grootegoed, J.A. Blok, L.J. |
2005-05-01
|
|
Phosphorylation of androgen receptor isoforms
(Article)
Wong, H.Y. Burghoorn, J.A. Brinkmann, A.O. Trapman, J. Leeuwen, M. van Ruiter, P.E. de Schippers, E. Blok, L.J. Li, K.W. Dekker, H.L. Jong, L. de Grootegoed, J.A. |
2004-10-15
|
|
Progestogenic effects of tibolone on human endometrial cancer cells
(Article)
Blok, L.J. Ruiter, P.E. de Kuhne, E.C. Hanekamp, E.E. Grootegoed, J.A. Smid-Koopman, E. Gielen, S.C.J.P. Gooyer, M.E. de Kloosterboer, H.J. Burger, C.W. |
2003-01-01
|
|
Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer
(Article)
Hanekamp, E.E. Blok, L.J. Huikeshoven, F.J. Gielen, S.C.J.P. Smid-Koopman, E. Kühne, L.C. Ruiter, P.E. de Chadha-Ajwani, S. Brinkmann, A.O. Grootegoed, J.A. Burger, C.W. |
2003-01-01
|
|
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations
(Article)
Boehmer, A.L.M. Halley, D.J.J. Rodrigues, C. Otten, B.J. Mendonça, B.B. Delemarre-van de Waal, H.A. Rouwé, C.W. Brinkmann, A.O. Sandkuijl, L.A. Ruiter, P.E. de Niermeijer, M.F. Andersson, S. Jong, F.H. de Bode, H.H. Drop, S.L.S. Kayserili, H. Vroede, M.A. de |
1999-01-01
|
|
In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein
(Article)
Kuiper, G.G.J.M. Ruiter, P.E. de Trapman, J. Jenster, G.W. Brinkmann, A.O. |
1993-01-01
|
